Loading...

FITC anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-f11
C57BL/6 splenocytes stained with 30-F11 FITC
  • 30-f11
    C57BL/6 splenocytes stained with 30-F11 FITC
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
103107 50 µg 29€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103108 500 µg 84€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Garo LP, et al. 2021. Nat Commun. 12:2419. PubMed
  2. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  3. Nederlof R, et al. 2022. Front Immunol. 13:908023. PubMed
  4. Kataru RP, et al. 2021. Sci Signal. 14:. PubMed
  5. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  6. Johnson DC, et al. 2018. Nat Med. 24:1151. PubMed
  7. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  8. Xu X, et al. 2020. Chin Med. 15:33. PubMed
  9. Shakya S, et al. 2020. MethodsX. 7:101027. PubMed
  10. J Gautam, X Zhang, Y Yao 2016. Sci Rep. 6:36450. PubMed
  11. Li Y, et al. 2020. Nat Commun. 2.350694444. PubMed
  12. Gabitova-Cornell L, et al. 2020. Cancer Cell. 38(4):567-583.e11. PubMed
  13. Hofmann I, et al. 2022. J Pharmacol Exp Ther. Online ahead of print. PubMed
  14. Hulsebus HJ, et al. 2022. Front Immunol. 13:884719. PubMed
  15. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  16. El-Hindi K, et al. 2022. Int J Mol Sci. 23:. PubMed
  17. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  18. Ma J, et al. 2020. Adv Sci (Weinh). 7:2000609. PubMed
  19. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  20. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  21. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  22. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  23. Tcheng M, et al. 2021. Blood. 137:3518. PubMed
  24. Prado C, et al. 2021. J Neuroinflammation. 18:292. PubMed
  25. Wang M, et al. 2022. Theranostics. 12:4513. PubMed
  26. Adachi Y, et al. 2022. Nat Commun. 13:5117. PubMed
  27. Bauer KM, et al. 2022. JCI Insight. 7:. PubMed
  28. Sepe JJ, et al. 2022. JACC Basic Transl Sci. 7:915. PubMed
  29. Zhu H, et al. 2018. Elife. 7:. PubMed
  30. Abdala-Valencia H, et al. 2014. Am J Physiol Lung Cell Mol Physiol. 307:482. PubMed
  31. Pan D, et al. 2022. Cancer Res. 82:2748. PubMed
  32. Rao E, et al. 2021. Sci Immunol. 6:. PubMed
  33. Saito S, et al. 2020. Nutrients. 12:. PubMed
  34. Shao Y, et al. 2019. Diabetes. 68:2131. PubMed
  35. Lee AK, et al. 2020. Radiat Res. 193:305. PubMed
  36. Choi H et al. 2019. Cell Rep. 27(3):806-819 . PubMed
  37. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  38. Neumann AM et al. 2017. PloS one. 12(11):e0187330 . PubMed
  39. Liu X, et al. 2020. Nature. . PubMed
  40. Liang W, et al. 2020. Nat Commun. 4.563888889. PubMed
  41. Ihara S, et al. 2022. PLoS Negl Trop Dis. 16:e0010323. PubMed
  42. Talma N, et al. 2021. Aging Cell. 20:e13450. PubMed
  43. Zhang Q, et al. 2019. PLoS Biol. 17:e3000330. PubMed
  44. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  45. Ohigashi I, et al. 2020. Cell Reports. 29(9):2901-2916.e6.. PubMed
  46. Zhao G, et al. 2020. Sci Adv. 6:00. PubMed
  47. Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
  48. Wosczyna MN, et al. 2021. Cell Stem Cell. 28(7):1323-1334.e8. PubMed
  49. Pan H, et al. 2020. Mol Psychiatry. . PubMed
  50. Wang X, et al. 2021. Front Cell Dev Biol. 632805:9. PubMed
  51. Dai B, et al. 2022. Theranostics. 12:7603. PubMed
  52. Francian A, et al. 2021. J Drug Target. 29:754. PubMed
  53. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  54. Rolfes S, et al. 2020. Neurobiol Dis. 144:105024. PubMed
  55. Zhang Z, et al. 2021. Oncoimmunology. 10:1912472. PubMed
  56. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  57. Lu Y, et al. 2020. Cell. 180(6):1081-1097. PubMed
  58. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  59. Xiao X, et al. 2019. Cell Discov. 5:2. PubMed
  60. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  61. Zhang W, et al. 2021. Cell Prolif. 54:e13058. PubMed
  62. Gui J, et al. 2020. Nat Cancer. 1:603. PubMed
  63. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  64. Dane EL, et al. 2022. Nat Mater. 21:710. PubMed
  65. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  66. Koujah L, et al. 2021. Ocul Surf. 21:238. PubMed
  67. Kumari A, et al. 2022. Sci Rep. 12:15273. PubMed
  68. Li P, et al. 2021. Nat Immunol. 22:1107. PubMed
  69. Zhang X, et al. 2022. Cells. 11:. PubMed
  70. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  71. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  72. Feng Y, et al. 2018. Kidney Dis (Basel). 4:95. PubMed
  73. Wosczyna MN et al. 2019. Cell Rep. 27(7):2029-2035 . PubMed
  74. Plein A, et al. 2018. Nature. 562:223. PubMed
  75. Kobayashi S, et al. 2019. J Immunol. 203:1447. PubMed
  76. Green DP, et al. 2019. Neuron. 101:412. PubMed
  77. Davidson S, et al. 2020. Cell Reports. 31(7):107628. PubMed
  78. Kucinski I, et al. 2020. EMBO J. :e104983. PubMed
  79. Müller A, et al. 2020. J Clin Invest. 5765:130. PubMed
  80. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  81. Zein HS, et al. 2022. Sci Rep. 12:4834. PubMed
  82. Luo W, et al. 2022. Front Immunol. 13:816761. PubMed
  83. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  84. Barman PK, et al. 2019. J Immunol. 202:2720. PubMed
  85. Lim D, et al. 2018. Front Physiol. 9:47. PubMed
  86. Kusuyama J, et al. 2021. Cell Metabolism. 33(5):939-956.e8. PubMed
  87. Morimoto A, et al. 2021. Nat Commun. 12:2136. PubMed
  88. Poillet-Perez L, et al. 2020. Nat Cancer. 1:923. PubMed
  89. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  90. Gañán-Gómez I, et al. 2022. Nat Med. . PubMed
  91. Chin AL, et al. 2021. Nat Commun. 12:5138. PubMed
  92. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  93. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  94. Cervera–Carrascon V, et al. 2020. Oncoimmunology. 9:1761229. PubMed
  95. Zhang K, et al. 2014. PLoS Pathog. 10:1004385. PubMed
  96. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  97. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  98. Hu J, et al. 2020. Theranostics. 7.154166667. PubMed
  99. Li J, et al. 2020. Elife. 9:00. PubMed
  100. Rosa JM, et al. 2021. British Journal of Pharmacology. . PubMed
  101. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  102. Goldfarb Y, et al. 2021. J Exp Med. 218:. PubMed
  103. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  104. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  105. Wan X, et al. 2018. Nature. 560:107. PubMed
  106. Al–Zaher AA, et al. 2018. Mol Ther Oncolytics. 0.376388889. PubMed
  107. Hepler C et al. 2018. eLife. 7 pii: e39636. PubMed
  108. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  109. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  110. Nguyen PT, et al. 2020. Cell. 182(2):388-403.e15. PubMed
  111. Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
  112. Ruan C, et al. 2020. Brain Behav Immun. 83:180. PubMed
  113. Sefik E, et al. 2021. Nat Biotechnol. . PubMed
  114. Cai Y, et al. 2019. Cell Rep. 27:3034. PubMed
  115. Crowell PD et al. 2019. Cell Rep. 28(6):1499-1510 . PubMed
  116. Maetzig T, et al. 2017. Mol Ther. 25:606. PubMed
  117. Burr ML, et al. 2019. Cancer Cell. 36:385. PubMed
  118. Wang F, et al. 2019. MAbs. 12:1685350. PubMed
  119. Ji DX, et al. 2019. Nat Microbiol. 1.644444444. PubMed
  120. Liu S, et al. 2020. Cell Host & Microbe. 26(6):779-794.e8.. PubMed
  121. Liang J, et al. 2020. Sci Adv. 6:eabc3646. PubMed
  122. Watanabe Y, et al. 2020. J Biol Chem. 295:17632. PubMed
  123. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  124. Milner MT, et al. 2022. STAR Protoc. 3:101295. PubMed
  125. Zhang X, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  126. Xiao L, et al. 2021. Clin Cancer Res. 27:4338. PubMed
  127. Kotas ME, et al. 2022. JCI Insight. :. PubMed
  128. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  129. Jiang Y, et al. 2021. Cell Death Differ. 28:3009. PubMed
  130. Agelidis A, et al. 2021. JCI Insight. 6: . PubMed
  131. Coronel MM, et al. 2020. Sci Adv. 6:eaba5573. PubMed
  132. Pundir P, et al. 2020. Cell Host & Microbe. 26(1):114-122. PubMed
  133. Gastelum‐Aviña P et al. 2016. Journal of immunological methods. 438:42-50 . PubMed
  134. Zhou J, et al. 2019. Nat Commun. 10:2427. PubMed
  135. Yu X, et al. 2019. Nat Commun. 10:574. PubMed
  136. Su S et al. 2018. Cell. 175(2):442-457 . PubMed
  137. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  138. Yamakawa D, et al. 2021. Cell Reports. 34(10):108817. PubMed
  139. Galle-Treger L, et al. 2016. Nat Commun. 7:13202. PubMed
  140. Hu Y, et al. 2021. Cell Death Dis. 12:743. PubMed
  141. Minhas PS, et al. 2021. Nature. 590:122. PubMed
  142. Zhang X, et al. 2021. Mol Cancer Res. 19:1076. PubMed
  143. Liu S, et al. 2022. J Neuroinflammation. 19:35. PubMed
  144. Xiao Y, et al. 2022. Nat Commun. 13:758. PubMed
  145. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  146. Yang Z, et al. 2021. Nat Commun. 12:4852. PubMed
  147. Long JT, et al. 2022. Elife. 11:. PubMed
  148. Bravo-Caparrós I, et al. 2020. FASEB J. 34:5951. PubMed
  149. Zhang P, et al. 2022. Nat Commun. 13:1588. PubMed
  150. Sirvinskas D, et al. 2022. iScience. 25:104202. PubMed
  151. Wang Z et al. 2018. Immunity. 49(1):80-92 . PubMed
  152. Sarvi S et al. 2018. Cell chemical biology. 25(12):1456-1469 . PubMed
  153. Ito K, et al. 2014. Proc Natl Acad Sci U S A. 111:3080. PubMed
  154. Saunders L, et al. 2015. Sci Transl Med. 7: 302ra136. PubMed
  155. Jiang Q, et al. 2020. JCI Insight. 5:00. PubMed
  156. Hasegawa T, et al. 2020. Sci Rep. 10:13480. PubMed
  157. Johnson DC, et al. 2020. Cell Death Dis. 0.894444444. PubMed
  158. Li CM, et al. 2020. Cell Reports. 33(13):108566. PubMed
  159. Zhang L, et al. 2021. iScience. 24(9):102942. PubMed
  160. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  161. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  162. Xu G, et al. 2022. Front Pharmacol. 13:896601. PubMed
  163. Zhou J, et al. 2022. Int J Oncol. 61: . PubMed
  164. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  165. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  166. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  167. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  168. Qi F, et al. 2019. Front Microbiol. 2.140277778. PubMed
  169. Yu JM, et al. 2019. Nat Commun. 4.388888889. PubMed
  170. Kim H, et al. 2020. Biomed Rep. 0.589583333. PubMed
  171. Zheng B, et al. 2021. Bioact Mater. 6:3879. PubMed
  172. Ferrer-Font L, et al. 2020. Elife. 9:. PubMed
  173. Sakai H, et al. 2022. iScience. 25:103928. PubMed
  174. Walker MT, et al. 2021. Front. Allergy. 2:. PubMed
  175. Kataru RP, et al. 2022. Front Aging. 3:864860. PubMed
  176. Pan Y, et al. 2021. Br J Pharmacol. 178:4907. PubMed
  177. Tomimatsu M, et al. 2022. Sci Rep. 12:16656. PubMed
  178. Ovadya Y, et al. 2018. Nat Commun. 9:5435. PubMed
  179. Hameed H, et al. 2022. Int J Mol Sci. 23:. PubMed
  180. Ding R, et al. 2022. J Neuroinflammation. 19:137. PubMed
  181. Liu R, et al. 2020. Eur J Vasc Endovasc Surg. 60:254. PubMed
  182. Fan ZP, et al. 2021. Front Immunol. 12:743354. PubMed
  183. Chen M, et al. 2019. Cell Stem Cell. 25:501. PubMed
  184. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  185. Liu L et al. 2018. Cell stem cell. 23(4):544-556 . PubMed
  186. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  187. Okada R, et al. 2021. EBioMedicine. 67:103345. PubMed
  188. Chen L, et al. 2021. Theranostics. 11:6668. PubMed
  189. Sugita Y, et al. 2021. Oncol Rep. 45:. PubMed
  190. Banskota S, et al. 2021. Inflamm Bowel Dis. 27:914. PubMed
  191. Ruan Y, et al. 2022. Exp Ther Med. 23:47. PubMed
  192. Wang R, et al. 2022. J Immunother Cancer. 10:. PubMed
  193. Liao X, et al. 2022. JCI Insight. 7:. PubMed
  194. Kelley WJ, et al. 2022. JCI Insight. 7: . PubMed
  195. Ding L et al. 2018. Cell reports. 25(11):2972-2980 . PubMed
  196. Hao T, et al. 2019. Nat Commun. 10:3665. PubMed
  197. Zegarra‐Ruiz DF et al. 2018. Cell host & microbe. 25(1):113-127 . PubMed
  198. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  199. Kataru RP, et al. 2019. Cancer Immunol Res. 7:1345. PubMed
  200. Krivtsov AV, et al. 2020. Cancer Cell. 36(6):660-673.e11.. PubMed
  201. Hu X, et al. 2020. Neoplasia. 1.290972222. PubMed
  202. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  203. Simoes Eugénio M, et al. 2020. Cancers (Basel). 12:00. PubMed
  204. Zhou Y, et al. 2022. Theranostics. 12:5488. PubMed
  205. Sheng D, et al. 2022. J Immunother Cancer. 10:. PubMed
  206. El-Obeid A, et al. 2021. Exp Ther Med. 22:1081. PubMed
  207. Tr änkner D, et al. 2019. Cell Rep. 29:791. PubMed
  208. Lee C, et al. 2020. Front Immunol. 11:77. PubMed
  209. Eckert EC, et al. 2020. Mol Ther Oncolytics. 0.710416667. PubMed
  210. Poillet–Perez L, et al. 2018. Nature. 563:569. PubMed
  211. Padhye A, et al. 2019. Sci Rep. 9:4819. PubMed
  212. Sharma R, et al. 2021. J Neuroinflammation. 72:18. PubMed
  213. Watanabe Y, et al. 2020. J Biol Chem. . PubMed
  214. Sheng J, et al. 2021. eLife. 10:00. PubMed
  215. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  216. Le TM et al. 2018. Journal of neurochemistry. 145(2):139-153 . PubMed
  217. Lee EKS, et al. 2018. Cell Host Microbe. 23:121. PubMed
  218. Shao Y, et al. 2019. Stem Cells. 37:1331. PubMed
  219. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  220. Gupta R, et al. 2020. Cell Stem Cell. 26:527. PubMed
  221. Li M, et al. 2020. Nat Commun. 4051:11. PubMed
  222. Li CY, et al. 2022. Int J Mol Sci. 23:. PubMed
  223. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  224. Zhang SJ, et al. 2021. Adv Sci (Weinh). 8:2003410. PubMed
  225. Zhang L, et al. 2021. Mol Ther. 29:744. PubMed
  226. Andreata F, et al. 2021. STAR Protoc. 2:100831. PubMed
  227. Ma Y, et al. 2020. Front Immunol. 11:586685. PubMed
  228. Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed
  229. Guarnerio J, et al. 2018. Nat Commun. 9:66. PubMed
  230. Wolf Y, et al. 2019. Cell. 179:219. PubMed
  231. Ichinose M, et al. 2021. Sci Rep. 7200:11. PubMed
  232. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  233. Dingler FA, et al. 2020. Mol Cell. . PubMed
  234. Wan Y, et al. 2020. Cell Rep. 33:108346. PubMed
  235. Badgujar DC, et al. 2020. PLoS Pathog. 16:e1009016. PubMed
RRID
AB_312972 (BioLegend Cat. No. 103107)
AB_312973 (BioLegend Cat. No. 103108)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 (Flexi-Fluor™) 30-F11 FC
Spark PLUS UV™ 395 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05.14.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account